OIS Gene Therapy Innovation Showcase 2021 https://t.co/p7FTBuvw25 via @YouTube A link to the event, if you missed it…. 1. Overview 2. A fantastic lineup of presenting companies 3. An expert panel, discussing challenges and differentiating solutions in #retinal #genetherapy Source by Thomas Ciulla, MD, MBA […]
Please join us on Feb 18 for fascinating discussion on #retina #genetherapy at https://t.co/i8BgpJqY8A We have a fantastic lineup of innovative companies, followed by an intriguing panel discussion with world class experts centered on current challenges & solutions. https://t.co/dGMcOQEJlY Source by Thomas Ciulla, MD, MBA […]
RT @ThomasCiullaMD: Honored to have been interviewed on Gene Therapy, by American Society of Retina Specialist’s @asrsdocs Tim Murray….…
Source by Thomas Ciulla, MD, MBA
Honored to have been interviewed on Gene Therapy, by American Society of Retina Specialist’s @asrsdocs Tim Murray…. #eyes #Ophthalmology #retina #genetherapy https://t.co/cIXkE5ZbMI Source by Thomas Ciulla, MD, MBA Return to main website.
Thank you so much Drs. Nguyen and Do for your kind invitation to participate in 2020 Sonoma Eye – Third Session on January 30 2020! Please join us at https://t.co/GAdGJ5Y1Br https://t.co/mGrUaE5t8j Source by Thomas Ciulla, MD, MBA Return to main website.
Just published: Even in common disorders such as diabetic macular edema, macular anatomy, often used for treatment decisions & clinical trial endpoints, has limited correlation to visual acuity.
#eyes #retina #diabetes #clinicalresearch #biotech #medicine
https://t.co/mVTtQ4N1N1
Source by Thomas Ciulla, MD, MBA
RT @ThomasCiullaMD: Just published: Precision medicine is predicated on genetic testing. However, barriers of cost, complexity, and unfam… Source by Thomas Ciulla, MD, MBA Return to main website.
Just published: Precision medicine is predicated on genetic testing. However, barriers of cost, complexity, and unfamiliarity with genetic testing illustrate unmet need. Educational efforts are underway. #eyes #retina #gene #genetics #genetherapy https://t.co/IAI8Lh5bi7 Source by Thomas Ciulla, MD, MBA Return to main website.
RT @ThomasCiullaMD: Just co-authored this paper on integrin inhibition, a potentially important pathway for treatment of common causes of v…
Source by Thomas Ciulla, MD, MBA
RT @PharmacDaily: Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspen… Source by Thomas Ciulla, MD, MBA Return to main website.